Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Effectiveness of Optomesh 3D for Inguinal Hernia Repair

NCT: NCT07836179 · NOT_YET_RECRUITING

NCT IDNCT07836179
StatusNOT_YET_RECRUITING
Start Date2026-11-01
Completion2028-02-01
SponsorSwissmed Hospital (OTHER)
First posted
Last updated

Brief Summary

OPTIMUS is an observational study assessing the safety and effectiveness of Optomesh 3D, a shaped surgical mesh used in planned keyhole surgery for a groin (inguinal) hernia. The mesh is placed without additional stitches, tacks, or glue to hold it in position. The study aims to include at least 300 patients from several hospitals. The main question is how often a hernia returns within 12 months after surgery. Researchers will also assess pain, postoperative complications, discomfort in the groin, and the feeling of having a foreign material in the operated area. Participants will provide written consent for the study. Information about their health and operation will be recorded. Follow-up information will be collected through telephone interviews at 7-10 days, 30 days, 3 months, and 12 months after surgery. The results will be assessed in relation to previously published findings on hernia repair.

Frequently Asked Questions

What is Safety and Effectiveness of Optomesh 3D for Inguinal Hernia Repair?

Safety and Effectiveness of Optomesh 3D for Inguinal Hernia Repair is a clinical trial registered under NCT07836179. Current status: NOT_YET_RECRUITING.

What is the status of NCT07836179?

The current status of NCT07836179 (Safety and Effectiveness of Optomesh 3D for Inguinal Hernia Repair) is: NOT_YET_RECRUITING.

When did Safety and Effectiveness of Optomesh 3D for Inguinal Hernia Repair start?

Safety and Effectiveness of Optomesh 3D for Inguinal Hernia Repair started on 2026-11-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.